TEL AVIV, Israel, May 3, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) and OTC Israel in cooperation with Israel Advanced Technology Industries (IATI) today announced they will hold an educational seminar for Israeli startup companies about cost-effectively raising capital and accessing the U.S. public markets on Tuesday, May 16, from 9:00 a.m. to 2:00 p.m. in Tel Aviv.
The event will feature presentations by representatives from OTC Markets Group, OTC Israel and IATI who will discuss the benefits and requirements of trading on the OTCQX and OTCQB markets in the U.S. In addition, an expert panel will discuss the legal and regulatory requirements, investor relations and other considerations around going public in the U.S. An investor panel will include the perspectives of various investors in Israeli public companies.
Guest speaker Amit Dror, CEO of Israeli technology company Nano Dimension Ltd., will discuss how the company successfully leveraged going public on the OTCQB and OTCQX markets in the U.S. to list on a national stock exchange. Other speakers will include: Jason Paltrowitz, EVP of Corporate Services for OTC Markets Group; Dov Weinberg, U.S. Director for OTC Israel; and Karin Mayer Rubinstein, CEO of IATI.
Operated by OTC Markets Group, the OTCQX and OTCQB are established U.S. public markets that provide a cost-effective alternative to a U.S. stock exchange listing for qualified U.S. and foreign companies, including Israeli companies. There are currently 1,270 OTCQX and OTCQB companies, ranging from large, global issuers such as Adidas, Heineken and Roche to established U.S. community banks and smaller and growing U.S. and international companies. OTCQX and OTCQB securities trade in excess of $6.1 billion monthly.
There are currently 70 Israeli companies traded on the OTCQX, OTCQB and Pink markets, including Collplant Holdings Ltd., Delta-Galil Industries Ltd., Elbit Vision Systems Ltd. and Jacada Ltd.
"The U.S. capital markets provide a tremendous opportunity for Israeli growth companies, but listing on a major U.S. stock exchange is simply too costly and burdensome for most early-stage businesses," said Mr. Paltrowitz. "OTCQX and OTCQB provide a proven path for Israeli startups to gain the benefits of a U.S. public market while allowing them to focus time, effort and capital on building their business. While the U.S. exchanges might be ideal for billion-dollar companies, OTCQX and OTCQB allow smaller issuers to grow in a logical, affordable way while limiting their risk."
"Going public on the OTCQX and OTCQB markets in the U.S. provides Israeli companies with wide exposure to the American and global capital markets, as well as the ability to upgrade to a U.S. stock exchange listing in the future," said Joseph Alon, CEO of OTC Israel.
The event is designed for CEOs, CFOs, Chairmen and other senior executives of Israeli startup companies with a global strategy and interest in the U.S. capital markets.
Registration is free, but space is limited so early registration is recommended. Lunch will be provided. To RSVP, contact Iris Golani at email@example.com or +972-52-8354596.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
About OTC Israel
OTC Israel works with OTC Markets Group in Israel. OTC Israel advises Israeli companies on raising capital and going public on the OTCQX and OTCQB markets in the U.S. OTC Israel also provides a complete suite of services to assist clients with a cost-effective approach to all aspects of successfully engaging U.S. investors, including expert IR, PR, and legal services.
IATI is Israel's umbrella organization of the high-tech, life science and other advanced technology industries, with about 700 paying members from every level and aspect of the ecosystem, including Venture Capital Funds, Israeli R&D Centers of Multinational Companies, Start-Ups, Incubators & Accelerators, Tech Transfer Organization, Academic Institutions, Innovation Centers, Hospitals, Municipalities, service Providers and more. Through this broad range of members, IATI connects Israel's tech ecosystem, provides solutions and support at all levels, and integrates the various sectors of the industry with strategic and ongoing governmental goals. For more about IATI, visit http://www.iati.co.il/.
SOURCE OTC Markets Group Inc.